Washington, USA
08048034998
+919359902383
ANTI CANCER MEDICINE

Lenakast 25mg Capsule (Lenalidomide) Bulk Exporter |Ernest Oncology| Buy Online USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, Asia

In stockcod not available
Phone Number

08048034998

Please keep 0 before dialling the number.

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Washington , District of Columbia , District of Columbia

Washington, USA, United States, 1

Description

Lenakast 25mg Capsule (Lenalidomide): Comprehensive Clinical Profile & Global Supply Guide Lenakast 25mg Capsule is a high-potency immunomodulatory drug (IMiD) containing the active pharmaceutical ingredient Lenalidomide. It is a cornerstone therapy in modern hematology and oncology, specifically designed to treat various plasma cell dyscrasias and complex blood cancers. As a structural analogue of thalidomide, Lenakast 25mg offers a targeted approach to inhibiting tumor growth while stimulating the body's natural immune response. Manufactured by Aprazer Healthcare, Lenakast is a trusted choice for oncology centers worldwide. Therapeutic Indications and Clinical Usage Lenakast 25mg is extensively utilized across global oncology protocols for: Multiple Myeloma (MM): Used in combination with dexamethasone for patients with newly diagnosed multiple myeloma or those who have received at least one prior therapy. It is also a primary choice for maintenance therapy following autologous stem cell transplantation (ASCT). Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after two prior therapies, providing a vital line of defense. Follicular Lymphoma & Marginal Zone Lymphoma: Employed in combination with rituximab for previously treated patients to achieve better remission rates and progression-free survival. The Mechanism: How Lenakast 25mg Works Lenakast exerts its anti-cancer effects through a sophisticated multi-pathway mechanism: Immune Modulation: It enhances T-cell and Natural Killer (NK) cell-mediated immunity, significantly increasing the body's innate ability to identify and destroy malignant cells. Anti-Angiogenesis: It blocks the secretion of vascular endothelial growth factor (VEGF), effectively preventing the formation of new blood vessels that tumors need to survive and spread. Direct Cytotoxicity: It induces cell cycle arrest and apoptosis (programmed cell death) specifically in hematopoietic tumor cells. Anti-Inflammatory Action: It inhibits the production of pro-inflammatory cytokines such as TNF-α and various Interleukins (IL-1, IL-6, and IL-12). Dosage and Administration Guidelines Cycle-Based Dosing: Typically administered in 28-day cycles. For multiple myeloma, the standard dose is 25 mg taken orally once daily on Days 1–21, followed by a 7-day rest period. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Timing: Can be taken with or without food, but should be taken at the same time each day to maintain steady therapeutic levels. Renal Monitoring: Since the drug is primarily excreted by the kidneys, dosage adjustments are strictly managed for patients with impaired renal function. Safety Profile and Side Effect Management Clinical management of Lenakast 25mg requires vigilant professional oversight: 1. Hematological Support The most frequent side effects are neutropenia (low white blood cells) and thrombocytopenia (low platelets). Regular blood counts (CBC) are mandatory to monitor for infection or bleeding risks. If counts drop too low, a dose reduction or temporary pause is usually implemented. 2. Thromboembolism Prophylaxis There is a significantly increased risk of blood clots (DVT or Pulmonary Embolism). Patients are almost always prescribed prophylactic anticoagulants (like aspirin or heparin) alongside Lenakast. 3. Embryo-Fetal Toxicity (REMS) Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs is mandatory for all patients of reproductive potential. 4. General Side Effects Commonly reported symptoms include fatigue, diarrhea, muscle cramps, and skin rashes. These are typically managed with supportive care, adequate hydration, and symptomatic medication. Storage and Handling Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Security: Keep in the original blister pack to protect from light and moisture. Safety: Caregivers should wear gloves if handling the capsules directly to avoid accidental skin exposure to the active powder. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ WHO-GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
Antibiotic Medicine

Cefepime Injection USP 500 mg—Product Information Guide Description Learn about Cefepime Injection USP 500 mg, including composition, category, clinical usage, safety precautions, storage, regulatory guidance, and export documentation support from Ernest Oncology. Cefepime Injection USP 500 mg Cefepime Injection USP 500 mg contains Cefepime, a broad-spectrum cephalosporin antibiotic used under medical supervision for the treatment of selected bacterial infections. It is generally supplied as a sterile powder for injection and should be administered only by a qualified healthcare professional. Product Profile: Understanding Cefepime Injection USP 500 mg Cefepime Injection USP 500 mg belongs to the fourth-generation cephalosporin antibiotic class. It is used for infections caused by susceptible bacteria and is commonly used in hospital and clinical settings. Key Product Information Brand Name: Cefepime Injection USP 500 mg Generic Name: Cefepime Strength: 500 mg Dosage Form: Powder for Injection Therapeutic Category: Cephalosporin Antibiotic Antibiotic Class: Fourth-Generation Cephalosporin Route of Administration: Intravenous / Intramuscular, as directed by physician Use Status: Prescription medicine Clinical Indications & Usage Cefepime may be prescribed by qualified healthcare professionals for selected bacterial infections depending on local treatment guidelines and approved indications. Common clinical applications may include: Pneumonia and lower respiratory tract infections Urinary tract infections Skin and soft tissue infections Intra-abdominal infections, usually with other suitable medicines Fever in patients with low white blood cell count, as directed by physician Mechanism of Action: How Cefepime Injection Works Cefepime works by interfering with bacterial cell wall synthesis. This weakens the bacterial cell wall and helps stop bacterial growth or kill susceptible bacteria. Step-by-Step Action The injection is administered by a healthcare professional. Cefepime enters the bloodstream or target tissue area. It reaches susceptible bacteria. It blocks bacterial cell wall formation. The bacteria become unable to maintain normal structure. The infection may improve when used appropriately under medical supervision. Administration and Handling Guide General handling points: Use only as prescribed by a licensed medical professional. Do not self-administer. Reconstitution and dilution should be done by trained medical staff. Follow sterile injection practices. Safety, Side Effects, and Monitoring Common Side Effects Injection-site pain or irritation Nausea Diarrhea Headache Rash Fever Serious Side Effects Severe allergic reaction Breathing difficulty Severe skin rash Seizures or confusion Severe weakness Precautions Inform your doctor about any allergy to cephalosporins, penicillins, or other antibiotics. Inform healthcare providers about kidney disease or dialysis. Inform your doctor about all medicines currently being used. Use only for bacterial infections confirmed or suspected by a qualified healthcare provider. Storage and Handling Specifications Store as per manufacturer’s recommended conditions. Protect from excessive heat and moisture. Keep out of reach of children. Do not use after expiry date. Regulatory and Compliance Documentation Certificate of Analysis Product specifications Batch details Manufacturing information Quality assurance documents Commercial invoice and packing list Export documentation support Frequently Asked Questions 1. What is Cefepime Injection USP 500 mg? Cefepime Injection USP 500 mg is an antibiotic injection containing Cefepime, used under medical supervision for selected bacterial infections. 2. What is the composition of Cefepime Injection USP 500 mg? The composition is Cefepime 500 mg, depending on manufacturer specification. 3. What is the dosage form? It is supplied as a sterile powder for injection. 4. What is the medicine category? It belongs to the fourth-generation cephalosporin antibiotic category. 5. Is Cefepime Injection a prescription medicine? Yes. Cefepime Injection is a prescription antibiotic and should be used only under medical supervision. PRESCRIPTION MEDICINE IS : YES Disclaimer Cefepime Injection USP 500 mg is a prescription antibiotic medicine. This information is for educational and export documentation purposes only. It is not medical advice. Use, sale, import, or distribution must follow applicable laws, prescription rules, and regulatory requirements. 📞 Contact Ernext Oncology - Pharmaceutical Medicine Exporter [Group of Ernest Pharmaceutical Pvt. Ltd.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | OEM Partner 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
Antibiotic Medicine

Cefepime Injection USP 1.0 gm—Product Information Guide Description Learn about Cefepime Injection USP 1.0 gm, including composition, category, clinical usage, safety precautions, storage, regulatory guidance, and export documentation support from Ernest Oncology. Cefepime Injection USP 1.0 gm Cefepime Injection USP 1.0 gm contains Cefepime, a broad-spectrum cephalosporin antibiotic used under medical supervision for the treatment of selected bacterial infections. It is generally supplied as a sterile powder for injection and should be administered only by a qualified healthcare professional. Product Profile: Understanding Cefepime Injection USP 1.0 gm Cefepime Injection USP 1.0 gm belongs to the fourth-generation cephalosporin antibiotic class. It is used for infections caused by susceptible bacteria and is commonly used in hospital and clinical settings. Key Product Information Brand Name: Cefepime Injection USP 1.0 gm Generic Name: Cefepime Strength: 1.0 gm Dosage Form: Powder for Injection Therapeutic Category: Cephalosporin Antibiotic Antibiotic Class: Fourth-Generation Cephalosporin Route of Administration: Intravenous / Intramuscular, as directed by physician Use Status: Prescription medicine Clinical Indications & Usage Cefepime may be prescribed by qualified healthcare professionals for selected bacterial infections depending on local treatment guidelines and approved indications. Common clinical applications may include: Pneumonia and lower respiratory tract infections Urinary tract infections Skin and soft tissue infections Intra-abdominal infections, usually with other suitable medicines Fever in patients with low white blood cell count, as directed by physician Other medically diagnosed bacterial infections caused by susceptible organisms Mechanism of Action: How Cefepime Injection Works Step-by-Step Action The injection is administered by a healthcare professional. Cefepime enters the bloodstream or target tissue area. It reaches susceptible bacteria. It blocks bacterial cell wall formation. The bacteria become unable to maintain normal structure. Administration and Handling Guide General handling points: Use only as prescribed by a licensed medical professional. Do not self-administer. Reconstitution and dilution should be done by trained medical staff. Follow sterile injection practices. Do not use damaged, discolored, or expired vials. Safety, Side Effects, and Monitoring Common Side Effects Injection-site pain or irritation Nausea Diarrhea Headache Rash Fever Mild stomach discomfort Serious Side Effects Severe allergic reaction Breathing difficulty Severe skin rash Persistent diarrhea Seizures or confusion Precautions Inform your doctor about any allergy to cephalosporins, penicillins, or other antibiotics. Inform healthcare providers about kidney disease or dialysis. Inform your doctor about all medicines currently being used. Use only for bacterial infections confirmed or suspected by a qualified healthcare provider. Pregnant or breastfeeding individuals should consult a healthcare professional before use. Storage and Handling Specifications Store as per manufacturer’s recommended conditions. Protect from excessive heat and moisture. Keep the vial in original packaging until use. Keep out of reach of children. Do not use after expiry date. Regulatory and Compliance Documentation Certificate of Analysis Product specifications Batch details Manufacturing information Quality assurance documents Commercial invoice and packing list Export documentation support Frequently Asked Questions: 1. What is Cefepime Injection USP 1.0 gm? Cefepime Injection USP 1.0 gm is an antibiotic injection containing Cefepime, used under medical supervision for selected bacterial infections. 2. What is the composition of Cefepime Injection USP 1.0 gm? The composition is Cefepime 1.0 gm, depending on manufacturer specification. 3. What is the dosage form? It is supplied as a sterile powder for injection. 4. What is the medicine category? It belongs to the fourth-generation cephalosporin antibiotic category. 5. Is Cefepime Injection a prescription medicine? Yes. Cefepime Injection is a prescription antibiotic and should be used only under medical supervision. PRESCRIPTION MEDICINE IS : YES Disclaimer Cefepime Injection USP 1.0 gm is a prescription antibiotic medicine. This information is for educational and export documentation purposes only. It is not medical advice. Use, sale, import, or distribution must follow applicable laws, prescription rules, and regulatory requirements. 📞 Contact Ernext Oncology - Pharmaceutical Medicine Exporter [Group of Ernest Pharmaceutical Pvt. Ltd.] 🌐 Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | OEM Partner 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
Androgenic Steroid

Yohimbine 5 mg Tablet – Product Information Guide: Yohimbine 5 mg Tablet | Yohimbine Tablets | Ernext Oncology Description Learn about Yohimbine 5 mg Tablet, including composition, category, safety precautions, storage, regulatory guidance, and export documentation support from Ernext Oncology. Yohimbine 5 mg Tablet Yohimbine 5 mg Tablet contains Yohimbine, an alpha-2 adrenergic antagonist medicine. It is generally used under medical supervision for selected conditions where adrenergic receptor activity may be clinically relevant. Product Profile: Understanding Yohimbine 5 mg Tablet Yohimbine 5 mg is generally supplied as an oral tablet. It belongs to the alpha-2 adrenergic antagonist / sexual wellness prescription medicine category and may be regulated differently depending on the country. Key Product Information Brand Name: Yohimbine 5 mg Generic Name: Yohimbine Strength: 5 mg Dosage Form: Tablet Therapeutic Category: Alpha-2 Adrenergic Antagonist Route of Administration: Oral Use Status: Prescription / regulated as per local rules Clinical & Regulatory Usage Note Yohimbine may be prescribed by qualified healthcare professionals for selected clinical conditions depending on approved indications and local treatment guidelines. Mechanism of Action: How Yohimbine 5 mg Works Yohimbine works mainly by blocking alpha-2 adrenergic receptors. This may influence nervous system signaling and blood flow-related pathways. Administration and Handling Guide General handling points: Use only as directed by a licensed medical professional. Do not self-medicate. Do not exceed prescribed instructions. Follow all prescription and import rules. Keep the product in original packaging. Do not use expired or damaged tablets. Safety, Side Effects, and Monitoring Yohimbine may cause side effects in some individuals, especially if misused or taken without professional supervision. Possible Side Effects Headache Dizziness Nausea Nervousness or anxiety Increased heart rate Blood pressure changes Sweating Sleep disturbance Mild stomach discomfort Precautions Not for self-medication. Not recommended without legal prescription or medical authorization. Inform a healthcare professional about heart disease, blood pressure problems, kidney disease, liver disease, anxiety disorders, or psychiatric conditions. Inform your doctor about all medicines, supplements, or herbal products currently being used. Avoid use during pregnancy or breastfeeding unless specifically advised by a qualified healthcare professional. Storage and Handling Specifications Store in a cool and dry place. Protect from direct sunlight. Keep away from heat and moisture. Keep out of reach of children. Keep tablets in original blister or container. Do not use after expiry date. Regulatory and Compliance Documentation Certificate of Analysis Batch details Product specification sheet Manufacturing information Quality documentation Commercial invoice and packing list Export documentation support Frequently Asked Questions 1. What is Yohimbine 5 mg Tablet? Yohimbine 5 mg Tablet contains Yohimbine, an alpha-2 adrenergic antagonist medicine used under medical supervision for selected clinical conditions. 2. What is the composition of Yohimbine 5 mg? The composition is Yohimbine 5 mg, depending on manufacturer specification. 3. What is the dosage form? It is supplied as an oral tablet. 4. What is the medicine category? Yohimbine 5 mg belongs to the alpha-2 adrenergic antagonist category. 5. Is Yohimbine 5 mg a prescription product? Yes. It should be treated as a prescription or regulated product depending on local rules. PRESCRIPTION MEDICINE IS: YES Disclaimer Yohimbine 5 mg is a prescription or regulated medicine in many markets. This information is for educational and export documentation purposes only. It is not medical advice. Use, sale, import, or distribution must follow applicable laws, prescription rules, and regulatory requirements. 📞C ontact Ernext Oncology - Pharmaceutical Medicine Exporter [Group of Ernest Pharmaceutical Pvt. Ltd.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | OEM Partner 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383